WESPAC Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,190
| Closed | -$794K | – | 164 |
|
|
2024
Q3 | $794K | Sell |
10,190
-652
| -6% | -$50.8K | 0.59% | 58 |
|
|
2024
Q2 | $846K | Sell |
10,842
-4,504
| -29% | -$351K | 0.66% | 53 |
|
|
2024
Q1 | $1.04M | Sell |
15,346
-13,610
| -47% | -$922K | 0.61% | 54 |
|
|
2023
Q4 | $1.95M | Buy |
28,956
+13,158
| +83% | +$886K | 1.35% | 15 |
|
|
2023
Q3 | $1.07M | Buy |
15,798
+781
| +5% | +$52.9K | 0.8% | 44 |
|
|
2023
Q2 | $1.07M | Sell |
15,017
-854
| -5% | -$61.1K | 0.86% | 41 |
|
|
2023
Q1 | $1.1M | Buy |
+15,871
| New | +$1.1M | 1.04% | 32 |
|
|
2022
Q4 | – | Sell |
-14,415
| Closed | -$791K | – | 67 |
|
|
2022
Q3 | $791K | Sell |
14,415
-5,896
| -29% | -$324K | 1.07% | 35 |
|
|
2022
Q2 | $1.34M | Buy |
+20,311
| New | +$1.34M | 1.02% | 31 |
|
|
2014
Q4 | – | Sell |
-24,790
| Closed | -$885K | – | 122 |
|
|
2014
Q3 | $885K | Buy |
24,790
+10,628
| +75% | +$379K | 0.71% | 60 |
|
|
2014
Q2 | $526K | Sell |
14,162
-9,820
| -41% | -$365K | 0.6% | 66 |
|
|
2014
Q1 | $778K | Sell |
23,982
-5,598
| -19% | -$182K | 0.67% | 64 |
|
|
2013
Q4 | $878K | Buy |
29,580
+10,698
| +57% | +$318K | 0.73% | 56 |
|
|
2013
Q3 | $490K | Buy |
+18,882
| New | +$490K | 0.57% | 69 |
|